Last reviewed · How we verify
NCT03558568: STN-DBS
The Effect of Deep Brain Stimulation on Facial Expressions.
NA trial testing Deep Brain Stimulation in Parkinson in 18 participants. Status unknown.
12 August 2019
Quick facts
| Lead sponsor | Mustafa Kemal University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 18 |
| Start date | 1 May 2018 |
| Primary completion | 12 August 2019 |
| Estimated completion | 1 December 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Deep Brain Stimulation
Conditions studied
- Parkinson — all drugs for Parkinson →
Sponsor
Mustafa Kemal University
Who can join
Adults 40 to 75, any sex, with Parkinson. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Whether Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS), a treatment commonly used to ameliorate the motor symptoms of Parkinson's disease (PD), affects on facial expressions is unclear. The purpose of this study was to investigate the potential effects of DBS and different frequencies on facial expressions of PD patients by volunteers via a web site: http://www.supporttoscience.com
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03558568
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Deep Brain Stimulation
Trials testing the same drug.
- NCT06924086 — The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial · NA · recruiting
- NCT07369401 — Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory · NA · not yet recruiting
- NCT07214467 — Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder · NA · recruiting
- NCT06991335 — VC/VS for Apathy in PD · NA · not yet recruiting
- NCT07049003 — Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor · Phase 1 · recruiting
Other recruiting trials for Parkinson
Currently open trials in the same condition.
- NCT07402928 — Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's · recruiting
- NCT07148700 — Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functi · recruiting
- NCT05931692 — Virtual Reality and Fear of Falling in Parkinson's Disease · recruiting
- NCT05286736 — Neuroplasticity in Parkinson's Disease · recruiting
- NCT03672266 — Studies of Brain and Body Interaction · recruiting
Other Mustafa Kemal University trials
Trials by the same sponsor.
- NCT07307430 — Effect of Narrative Education on Glycemic Control in Adults With Type 2 Diabetes in Primary Care · NA · not yet recruiting
- NCT05969652 — Comparison of the Effectiveness Heavy Slow Resistance and Eccentric Training in Rotator Cuff Tendinopathy · NA · not yet recruiting
- NCT07328685 — Basic Body Awareness Therapy in Individuals With Migraine · NA · not yet recruiting
- NCT06715397 — Cross-Cultural Adaptation, Validity and Reliability of the Turkish Version of the Adolfsson-Björnsson Upper Extremity Ac · enrolling by invitation
- NCT07375576 — Outcomes of Pulpotomy and Root Canal Treatment in Teeth With Symptomatic Irreversible Pulpitis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03558568 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mustafa Kemal University
- Last refreshed: 14 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03558568.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing